Interestingly, the BCR-ABL1 overexpression led to a significant lowering of HERC1 both at transcript and protein level (Figure 5B–D) in agreement with the findings in CML specimens at diagnosis. This evidence concerns the gene HERC1 and chronic myelogenous leukemia, BCR-ABL1 positive.